Suppr超能文献

使用人前列腺癌细胞系研究雄激素受体在前列腺癌中的作用所产生的多样且对比鲜明的效应。

The diverse and contrasting effects of using human prostate cancer cell lines to study androgen receptor roles in prostate cancer.

作者信息

Yu Sheng-Qiang, Lai Kuo-Pao, Xia Shu-Jie, Chang Hong-Chiang, Chang Chawnshang, Yeh Shuyuan

机构信息

Department of Urology, The First People's Hospital of Shanghai Jiao Tong University, Shanghai, China.

出版信息

Asian J Androl. 2009 Jan;11(1):39-48. doi: 10.1038/aja.2008.44. Epub 2008 Dec 22.

Abstract

The androgen receptor (AR) plays an important role in the development and progression of prostate cancer (PCa). Androgen deprivation therapy is initially effective in blocking tumor growth, but it eventually leads to the hormone-refractory state. The detailed mechanisms of the conversion from androgen dependence to androgen independence remain unclear. Several PCa cell lines were established to study the role of AR in PCa, but the results were often inconsistent or contrasting in different cell lines, or in the same cell line grown under different conditions. The cellular and molecular alteration of epithelial cells and their microenvironments are complicated, and it is difficult to use a single cell line to address this important issue and also to study the pathophysiological effects of AR. In this paper, we summarize the different effects of AR on multiple cell lines and show the disadvantages of using a single human PCa cell line to study AR effects on PCa. We also discuss the advantages of widely used epithelium-stroma co-culture systems, xenograft mouse models, and genetically engineered PCa mouse models. The combination of in vitro cell line studies and in vivo mouse models might lead to more credible results and better strategies for the study of AR roles in PCa.

摘要

雄激素受体(AR)在前列腺癌(PCa)的发生和发展中起着重要作用。雄激素剥夺疗法最初在阻断肿瘤生长方面有效,但最终会导致激素抵抗状态。从雄激素依赖转变为雄激素非依赖的详细机制仍不清楚。已建立了几种前列腺癌细胞系来研究AR在PCa中的作用,但在不同细胞系中,或在不同条件下培养的同一细胞系中,结果往往不一致或相互矛盾。上皮细胞及其微环境的细胞和分子改变很复杂,很难用单一细胞系来解决这一重要问题,也难以研究AR的病理生理效应。在本文中,我们总结了AR对多种细胞系的不同影响,并展示了使用单一人类前列腺癌细胞系研究AR对PCa影响的缺点。我们还讨论了广泛使用的上皮-基质共培养系统、异种移植小鼠模型和基因工程前列腺癌小鼠模型的优点。体外细胞系研究和体内小鼠模型的结合可能会产生更可靠的结果,并为研究AR在PCa中的作用提供更好的策略。

相似文献

2
Targeting the stromal androgen receptor in primary prostate tumors at earlier stages.
Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12188-93. doi: 10.1073/pnas.0804701105. Epub 2008 Aug 22.
3
Androgen Receptor Regulation of Local Growth Hormone in Prostate Cancer Cells.
Endocrinology. 2017 Jul 1;158(7):2255-2268. doi: 10.1210/en.2016-1939.
4
Krüppel-like factor 8 is a novel androgen receptor co-activator in human prostate cancer.
Acta Pharmacol Sin. 2013 Feb;34(2):282-8. doi: 10.1038/aps.2012.130. Epub 2012 Oct 1.
5
Androgen receptor is a tumor suppressor and proliferator in prostate cancer.
Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12182-7. doi: 10.1073/pnas.0804700105. Epub 2008 Aug 22.
10
Prostate fibroblasts enhance androgen receptor splice variant 7 expression in prostate cancer cells.
Prostate. 2023 Mar;83(4):364-375. doi: 10.1002/pros.24468. Epub 2022 Dec 7.

引用本文的文献

1
Phosphatidylserine-Gold Nanoparticles (PS-AuNP) Induce Prostate and Breast Cancer Cell Apoptosis.
Pharmaceutics. 2021 Jul 17;13(7):1094. doi: 10.3390/pharmaceutics13071094.
2
Characterization of FGFR signaling in prostate cancer stem cells and inhibition via TKI treatment.
Oncotarget. 2021 Jan 5;12(1):22-36. doi: 10.18632/oncotarget.27859.
3
Androgen Signaling in Esophageal Adenocarcinoma Cell Lines In Vitro.
Dig Dis Sci. 2017 Dec;62(12):3402-3414. doi: 10.1007/s10620-017-4794-5. Epub 2017 Oct 20.
6
Androgen receptor coactivators that inhibit prostate cancer growth.
Am J Clin Exp Urol. 2014 Apr 5;2(1):62-70. eCollection 2014.
7
The androgen receptor transcriptional program in castration-resistant prostate cancer: cell lines vs. tissue samples.
Cancer Biol Ther. 2014 Jan;15(1):16-8. doi: 10.4161/cbt.27149. Epub 2013 Nov 19.
8
TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth.
Endocr Relat Cancer. 2014 Jan 16;21(1):127-42. doi: 10.1530/ERC-13-0293. Print 2014 Feb.

本文引用的文献

1
Androgen receptor is a tumor suppressor and proliferator in prostate cancer.
Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12182-7. doi: 10.1073/pnas.0804700105. Epub 2008 Aug 22.
2
Targeting the stromal androgen receptor in primary prostate tumors at earlier stages.
Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12188-93. doi: 10.1073/pnas.0804701105. Epub 2008 Aug 22.
3
Androgen inhibits the growth of carcinoma cell lines established from prostate cancer xenografts that escape androgen treatment.
J Steroid Biochem Mol Biol. 2008 Jul;111(1-2):50-9. doi: 10.1016/j.jsbmb.2008.02.011. Epub 2008 Apr 20.
4
The current state of preclinical prostate cancer animal models.
Prostate. 2008 May 1;68(6):629-39. doi: 10.1002/pros.20726.
7
Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor.
Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12679-84. doi: 10.1073/pnas.0704940104. Epub 2007 Jul 25.
10
Hormonal and stromal regulation of normal and neoplastic prostatic growth.
Prog Mol Subcell Biol. 2005;40:183-216. doi: 10.1007/3-540-27671-8_8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验